Founded
Address
Clarus Ventures LLC
One Memorial Drive
Suite 1230
Cambridge, MA 02142
United States
Phone
Website
Recent investment activity
KANDO id: 30972
Company type
Life sciences venture capital firmRelation
Renamed to
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 26 - 38 of 38| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Aerovance Inc | N/A | ||||
|
|
Aerovance Inc | Series C | ||||
|
|
Biolex Therapeutics Inc | Series D | ||||
|
|
Cleave Biosciences Inc | Drug development company focused on novel targets in cellular protein homeostasis pathways | Series A | |||
|
|
ESBATech AG | Switzerland based Biomedical Research Unit of Alcon | Series B Initial investment | |||
|
|
ESBATech AG | Switzerland based Biomedical Research Unit of Alcon | Series B Initial investment | |||
|
NanoString Technologies Inc | A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. | Series D | |||
|
|
NanoString Technologies Inc | A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. | Series C | |||
|
|
Oxford Immunotec Ltd | Venture | ||||
|
|
Oxford Immunotec Ltd | Series D | ||||
|
|
Oxford Immunotec Ltd | Series C led the round | ||||
|
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | Series B Follow-on investment | |||
|
|
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | N/A Initial investment |